LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

Clascoterone cream 1% used twice daily for 2 weeks had no effect on transepidermal water loss of the skin barrier and ...

A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...

Delgocitinib cream had superior efficacy and a better safety profile compared with oral alitretinoin for the treatment of ...

"Patients and consumers are expecting more and more from topical skin care these days ... "Some of the regenerative ...

For the most part, early attention with topical treatments is the first line of all-natural defense, especially if you’re in your 20s and 30s. But if expensive creams and chemical peels are no ...

today announced that Health Canada has approved NDUVRA (tapinarof cream), 1%, the first in a novel class of aryl hydrocarbon receptor agonists to be approved in Canada, for the topical treatment ...

Step one is to find a cream with hyaluronic acid and centella ... Further, he also that a few topical retinoids, when applied twice daily, also show some benefits. Acne products may show similar ...

Camp reminds us that, topical serums will not deliver the same type of results as in-office procedures like neurotoxin injections. And, as someone who regularly receives Botox injections, I don’t this ...